The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

So now I don't have my prescription, and the actual physical CVS won't fill my prescription because it's too soon to fill it. I feel like someone has tampered with my medication. And I don't want ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...

The "RIG" portfolio aims for 50% income from defensive sectors and includes 83 stocks across 11+ sectors, focusing on ...

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on CVS Health (CVS – Research Report), with a price target of ...

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of ...

Zydus Lifesciences announced that it has entered into an agreement with CVS Caremark, a CVS Health (CVS) company, to add Zituvio, Zituvimet and Zituvimet XR tablets to its template formulary.